In this study, we found that the PT and PLT count were lower in patients with cerebral hemorrhage in the plateau, which suggests that we need to pay attention to the coagulation function of patients and adjust the dose of prothrombin used by patients in a timely manner to avoid HE due to excessive platelet consumption and abnormal coagulation function. The gene discussed is F2; the disease is hereditary elliptocytosis.